Alzheimer’s disease (AD) stands as the predominant neurodegenerative condition in the aging population, clinically manifesting through memory-related cognitive decline and pathologically distinguished by the presence of extracellular plaques rich in β-amyloid (Aβ) and intracellular neurofibrillary tangles composed of tau protein. Here, MAPT is linked to Alzheimer disease.